Metraipolis › archive › dc_d2a624a8dcaa

When Should Clinical Mycology Laboratories Perform Antifungal Susceptibility Testing? Revisiting Practice Through the Lens of Intrinsic Resistance — Europe PMC PMID:41422195

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41422195
DOI
10.1007/s11046-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-07T12:03:22.142Z
SHA-256 of the archived text
82417abff60736b0801a4887d846f91e9641519106a7b0e8c438cbb98a7a3edc
Stable URL of this page
https://metraipolis.com/documento/dc_d2a624a8dcaa

How to cite

When Should Clinical Mycology Laboratories Perform Antifungal Susceptibility Testing? Revisiting Practice Through the Lens of Intrinsic Resistance — Europe PMC PMID:41422195 — Europe PMC (en), https://europepmc.org/article/MED/41422195 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d2a624a8dcaa (Metraipolis archive dc_d2a624a8dcaa, sha256 82417abff60736b0801a4887d846f91e9641519106a7b0e8c438cbb98a7a3edc)
BibTeX
@misc{dcd2a624a8dcaa,
  title = {When Should Clinical Mycology Laboratories Perform Antifungal Susceptibility Testing? Revisiting Practice Through the Lens of Intrinsic Resistance — Europe PMC PMID:41422195},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41422195},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d2a624a8dcaa; sha256 82417abff60736b0801a4887d846f91e9641519106a7b0e8c438cbb98a7a3edc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41422195. Agents can read the archived copy with the MCP tool read_document.